Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
A. Nassar-Sheikh Rashid
D. Schonenberg-Meinema
S. C. Bergkamp
S. Bakhlakh
A. de Vries
T. Rispens
T. W. Kuijpers
G. Wolbink
J. M. van den Berg
机构：
[1] University of Amsterdam,Zaans Medical Center, Zaandam and Emma Children’s Hospital, Amsterdam UMC, Pediatric Immunology, Rheumatology and Infectious Diseases
[2] University of Amsterdam,Emma Children’s Hospital, Amsterdam UMC, Pediatric Immunology, Rheumatology and Infectious Diseases
[3] Department of Immunopathology,Department of Immunopathology, CLB Sanquin Amsterdam and Department of Rheumatology
[4] Sanquin Diagnostic Services Amsterdam,undefined
[5] Department of Immunopathology,undefined
[6] Sanquin Research and Landsteiner Laboratory,undefined
[7] Jan van Breemen Institute Amsterdam,undefined
来源：
Pediatric Rheumatology | / 19卷
关键词：
Biologics; Anti-TNF drug trough levels; Anti-drug antibodies; Children; Juvenile idiopathic arthritis (JIA);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
    Nassar-Sheikh Rashid, A.
    Schonenberg-Meinema, D.
    Bergkamp, S. C.
    Bakhlakh, S.
    de Vries, A.
    Rispens, T.
    Kuijpers, T. W.
    Wolbink, G.
    van den Berg, J. M.
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [2] THERAPEUTIC DRUG MONITORING OF BIOLOGICALS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA): AN OVERVIEW OF CURRENT PRACTICE IN ANTI-TNF THERAPY
    Rashid, A. Nassar-Sheikh
    Schonenberg-Meinema, D.
    de Vries, A.
    Rispens, T.
    Kuijpers, T. W.
    Wolbink, G.
    van den Berg, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 480 - 481
  • [3] DISCONTINUATION OF ANTI-TNF IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN CLINICAL REMISSION
    Camacho-Lovillo, M.
    Gil-Gonzaez, E.
    Pedraza, M. A. Gantes
    Lopez-Sabido, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 388 - 388
  • [4] Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis
    Tynjala, P.
    Lahdenne, P.
    Vahasalo, P.
    Kautiainen, H.
    Honkanen, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) : 1044 - 1049
  • [5] A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs
    Reinink, Andrew R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (12): : 1892 - 1893
  • [6] TREATMENT WITH TOCILIZUMAB IMPROVED RHEUMATOID ARTHRITIS PATIENTS CLINICALLY AND STRUCTURALLY REGARDLESS OF THE PRIOR USE OF ANTI-TNF BIOLOGICS IN DAILY CLINICAL PRACTICE
    Izumi, K.
    Kaneko, Y.
    Yasuoka, H.
    Seta, N.
    Kameda, H.
    Kuwana, M.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 884 - 885
  • [7] Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis
    Taddio, Andrea
    Cattalini, Marco
    Simonini, Gabriele
    Cimaz, Rolando
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (06) : 641 - 649
  • [8] Monitoring of gene expression of patients with juvenile idiopathic arthritis (JIA) treated with anti-TNFα applying DNA-chip technology.
    Kekow, J
    Koczan, D
    Kekow, M
    Drynda, S
    Thiesen, HJ
    Guthke, R
    Oppermann, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S364 - S364
  • [9] A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs Response
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (12): : 1893 - 1894
  • [10] Therapeutic drug monitoring of anti-TNFα drugs in a UK tertiary IBD unit
    Barrow, V.
    Innes, A.
    Thompson, N.
    Mansfield, J.
    Speight, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S416 - S417
12345